arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

Penumbra Inc

PEN
$321.25 ▼ -1.25 (-0.39%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
52 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
70
Health
Good
Neutral
auto_awesome

Analytical Summary

Penumbra Inc shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $12.7B
Dividend Yield —
Revenue Growth 15.6% ↗
Op. Margin 12.4% ↗
ROIC 2.4% ↗
FCF / Share $0.67 ↘
Trailing P/E 300.2x
Price / Book 8.0x
FCF Yield 0.2%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

52-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$410.14M
↑ +15.6% —
Net Income Profit after all expenses
$32.58M
↓ -16.9% —
Operating Margin Operating profit as % of sales
12.4%
↑ +17.6% 64th
FCF / Share Free cash flow per share
$0.67
↓ -19.0% —

Health Breakdown

Profitability ↑
67
Returns
75
Cash Quality
65

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 14 years · 52 quarters